Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1982
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 1
1987 1
1988 2
1989 4
1990 1
1991 2
1992 5
1993 6
1994 5
1995 1
1996 4
1997 3
1998 8
1999 2
2000 5
2001 11
2002 6
2003 2
2004 2
2005 4
2006 3
2007 8
2008 12
2009 7
2010 6
2011 11
2012 10
2013 14
2014 7
2015 5
2016 5
2017 9
2018 7
2019 14
2020 12
2021 6
2022 7
2023 4
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Neonatal Alloimmune Thrombocytopenia: A Concise Review.
Norton T, Newberry D, Jnah A. Norton T, et al. Adv Neonatal Care. 2021 Apr 1;21(2):115-121. doi: 10.1097/ANC.0000000000000775. Adv Neonatal Care. 2021. PMID: 32657948 Review.
BACKGROUND: Neonatal alloimmune thrombocytopenia (NAIT) is defined as an uncommon platelet disorder caused by maternal alloimmunization to human-specific antigens (HPAs) that are paternally inherited, resulting in low fetal/neonatal platelet levels and …
BACKGROUND: Neonatal alloimmune thrombocytopenia (NAIT) is defined as an uncommon platelet disorder caused by maternal …
New developments in fetal and neonatal alloimmune thrombocytopenia.
Bussel JB, Vander Haar EL, Berkowitz RL. Bussel JB, et al. Am J Obstet Gynecol. 2021 Aug;225(2):120-127. doi: 10.1016/j.ajog.2021.04.211. Epub 2021 Apr 8. Am J Obstet Gynecol. 2021. PMID: 33839095 Review.
Fetal and neonatal alloimmune thrombocytopenia, the platelet equivalent of hemolytic disease of the fetus and newborn, can have devastating effects on both the fetus and neonate. ...This commentary describes 4 advances that could substantially change the curr …
Fetal and neonatal alloimmune thrombocytopenia, the platelet equivalent of hemolytic disease of the fetus and newborn, …
How I diagnose and treat neonatal thrombocytopenia.
Stanworth SJ, Mumford AD. Stanworth SJ, et al. Blood. 2023 Jun 1;141(22):2685-2697. doi: 10.1182/blood.2022018017. Blood. 2023. PMID: 36787503 Free article. Review.
Neonatal thrombocytopenia, defined as the presence of a circulating platelet count <150 109/L, is a common abnormality in babies admitted to neonatal intensive care units. ...Distinguishing these causes of thrombocytopenia from entities such as gene
Neonatal thrombocytopenia, defined as the presence of a circulating platelet count <150 109/L, is a common abnormality in b
Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach.
Lieberman L, Greinacher A, Murphy MF, Bussel J, Bakchoul T, Corke S, Kjaer M, Kjeldsen-Kragh J, Bertrand G, Oepkes D, Baker JM, Hume H, Massey E, Kaplan C, Arnold DM, Baidya S, Ryan G, Savoia H, Landry D, Shehata N; International Collaboration for Transfusion Medicine Guidelines (ICTMG). Lieberman L, et al. Br J Haematol. 2019 May;185(3):549-562. doi: 10.1111/bjh.15813. Epub 2019 Mar 3. Br J Haematol. 2019. PMID: 30828796 Free article.
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) may result in severe bleeding, particularly fetal and neonatal intracranial haemorrhage (ICH). ...Ideally, HPA-selected platelets should be available at delivery for potentially affected infants an …
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) may result in severe bleeding, particularly fetal and neonata
Neonatal thrombocytopenia: A review. I. Definitions, differential diagnosis, causes, immune thrombocytopenia.
Donato H. Donato H. Arch Argent Pediatr. 2021 Jun;119(3):e202-e214. doi: 10.5546/aap.2021.eng.e202. Arch Argent Pediatr. 2021. PMID: 34033425 Free article. Review. English, Spanish.
It also describes the different causative mechanisms and reviews the varying characteristics of thrombocytopenia secondary to maternal immune thrombocytopenia and neonatal alloimmune thrombocytopenia. The different treatment approaches to each o …
It also describes the different causative mechanisms and reviews the varying characteristics of thrombocytopenia secondary to materna …
Immune-Mediated Neonatal Thrombocytopenia.
Batton E, Leibel SL. Batton E, et al. Neoreviews. 2022 Jul 1;23(7):e462-e471. doi: 10.1542/neo.23-7-e462. Neoreviews. 2022. PMID: 35773506 Review.
Immune-mediated thrombocytopenia in neonates is caused by the transplacental passage of maternally derived antiplatelet antibodies. The 2 most common causes include neonatal alloimmune thrombocytopenia, which leads to significant thrombocytopenia
Immune-mediated thrombocytopenia in neonates is caused by the transplacental passage of maternally derived antiplatelet antibodies. T …
Foetal and neonatal alloimmune thrombocytopenia.
Winkelhorst D, Oepkes D. Winkelhorst D, et al. Best Pract Res Clin Obstet Gynaecol. 2019 Jul;58:15-27. doi: 10.1016/j.bpobgyn.2019.01.017. Epub 2019 Feb 6. Best Pract Res Clin Obstet Gynaecol. 2019. PMID: 30827816 Review.
Foetal or neonatal thrombocytopenia results from alloimmunisation during pregnancy. Maternal alloantibodies can be formed following exposure to paternally derived human platelet antigens (HPAs) on foetal platelets, in case of incompatible HPA type. ...Subsequent cli …
Foetal or neonatal thrombocytopenia results from alloimmunisation during pregnancy. Maternal alloantibodies can be formed foll …
Fetal/neonatal alloimmune thrombocytopenia.
Sachs UJ. Sachs UJ. Thromb Res. 2013 Jan;131 Suppl 1:S42-6. doi: 10.1016/S0049-3848(13)70020-3. Thromb Res. 2013. PMID: 23452741 Review.
In fetal/neonatal alloimmune thrombocytopenia (FNAIT), antibodies against paternal antigens present on fetal platelets are produced by the mother. These antibodies will cross the placenta and can cause thrombocytopenia of the unborn. One severe consequ …
In fetal/neonatal alloimmune thrombocytopenia (FNAIT), antibodies against paternal antigens present on fetal platelets …
Research Progress in Neonatal Alloimmune Thrombocytopenia: A Narrative Review.
Zhou E, Wang K, Gu Y. Zhou E, et al. Altern Ther Health Med. 2023 Sep;29(6):77-81. Altern Ther Health Med. 2023. PMID: 37318890 Free article. Review.
BACKGROUND: Neonatal alloimmune thrombocytopenia (NAIT) is an immune disorder characterized by maternal antibodies that destroy fetal platelets, leading to thrombocytopenia. ...OBJECTIVE: This study aims to assess the current advancements in the pathog …
BACKGROUND: Neonatal alloimmune thrombocytopenia (NAIT) is an immune disorder characterized by maternal antibodies that …
Fetal and neonatal alloimmune thrombocytopenia.
Zdravic D, Yougbare I, Vadasz B, Li C, Marshall AH, Chen P, Kjeldsen-Kragh J, Ni H. Zdravic D, et al. Semin Fetal Neonatal Med. 2016 Feb;21(1):19-27. doi: 10.1016/j.siny.2015.12.004. Epub 2016 Jan 20. Semin Fetal Neonatal Med. 2016. PMID: 26810319 Review.
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an alloimmune disorder resulting from platelet opsonization by maternal antibodies that destroy fetal platelets. ...Miscarriage has also been reported but the incidence requires further study. A …
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an alloimmune disorder resulting from platelet opsoniz …
201 results